Write a reviewFor vendors
♡
Home / Investors / Kevin Bitterman

Kevin Bitterman

Venture Fund · Cambridge

About Kevin Bitterman

Venture capital investor (Partner) based in Cambridge, Massachusetts. Focus areas include Health Care, Drug Discovery, Wellness. Invests at series b stage. Past investments include Neuronetics, Inc., Magenta Therapeutics, Remix Therapeutics.

Investment focus

Stages
Series B
Sectors
Health CareDrug DiscoveryWellnessWomen FoundedImmunotherapyHealthcare InnovationLife SciencePortfolio ManagementMedical TechnologiesStartupsFinanceBioinformaticsBiotechnologyDrug DevelopmentElectronic Health Records (EHR)Health and Hospital ServicesPrecision MedicineClinical TrialsGene TherapyTechnology Transfer

Portfolio

No portfolio companies recorded yet; Kevin Bitterman reports 60 investments overall.

Similar investors

Aakash Tulsani

Venture Fund · Singapore
Series BHealth CareHospitalsE-commerceSports+16
60Investments
—Exits

Aaref Hilaly

Angel Investor · San Francisco
SeedSeries BEarly Stage VentureSeries AHealth CareData IntegrationTalent ManagementE-commerce+16
60Investments
—Exits

Aaron Goldman

Venture Fund · New York City
Series BHealth CareTalent ManagementE-commerceWellness+16
60Investments
—Exits

Adam Goulburn

Venture Fund · New York City
Series BHealth CareRegenerative MedicineDrug DiscoveryData Science+16
60Investments
—Exits

Adam Greene

Venture Fund · New York City
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)+14
60Investments
—Exits

Adam Margolin

Venture Fund · Boston
Series BAdvertisingHealth CareWearablesE-commerce+16
60Investments
—Exits